Pathophysiological role of leptin in obesity-related hypertension

Megumi Aizawa-Abe, Yoshihiro Ogawa, Hiroaki Masuzaki, Ken Ebihara, Noriko Satoh, Hidenori Iwai, Naoki Matsuoka, Tatsuya Hayashi, Kiminori Hosoda, Gen Inoue, Yasunao Yoshimasa, Kazuwa Nakao

Research output: Contribution to journalArticle

407 Citations (Scopus)

Abstract

To explore the pathophysiological role of leptin in obesity-related hypertension, we examined cardiovascular phenotypes of transgenic skinny mice whose elevated plasma leptin concentrations are comparable to those seen in obese subjects. We also studied genetically obese KKA(y) mice with hyperleptinemia, in which hypothalamic melanocortin system is antagonized by ectopic expression of the agouti protein. Systolic blood pressure (BP) and urinary catecholamine excretion are elevated in transgenic skinny mice relative to nontransgenic littermates. The BP elevation in transgenic skinny mice is abolished by α1-adrenergic, β-adrenergic, or ganglionic blockers at doses that do not affect BP in nontransgenic littermates. Central administration of an α-melanocyte-stimulating hormone antagonist causes a marked increase in cumulative food intake but no significant changes in BP. The obese KKA(y) mice develop BP elevation with increased urinary catecholamine excretion relative to control KK mice. After a 2-week caloric restriction, BP elevation is reversed in nontransgenic littermates with the A(y) allele, in parallel with a reduction in plasma leptin concentrations, but is sustained in transgenic mice overexpressing leptin with the A(y) allele, which remain hyperleptinemic. This study demonstrates BP elevation in transgenic skinny mice and obese KKA(y) mice that are both hyperleptinemic, thereby suggesting the pathophysiological role of leptin in some forms of obesity-related hypertension.

Original languageEnglish
Pages (from-to)1243-1252
Number of pages10
JournalJournal of Clinical Investigation
Volume105
Issue number9
DOIs
Publication statusPublished - Jan 1 2000

Fingerprint

Leptin
Obesity
Blood Pressure
Hypertension
Transgenic Mice
Catecholamines
Agouti Signaling Protein
Ganglionic Blockers
Alleles
Melanocortins
Melanocyte-Stimulating Hormones
Hormone Antagonists
Caloric Restriction
Adrenergic Antagonists
Adrenergic Agents
Eating
Phenotype

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Aizawa-Abe, M., Ogawa, Y., Masuzaki, H., Ebihara, K., Satoh, N., Iwai, H., ... Nakao, K. (2000). Pathophysiological role of leptin in obesity-related hypertension. Journal of Clinical Investigation, 105(9), 1243-1252. https://doi.org/10.1172/JCI8341

Pathophysiological role of leptin in obesity-related hypertension. / Aizawa-Abe, Megumi; Ogawa, Yoshihiro; Masuzaki, Hiroaki; Ebihara, Ken; Satoh, Noriko; Iwai, Hidenori; Matsuoka, Naoki; Hayashi, Tatsuya; Hosoda, Kiminori; Inoue, Gen; Yoshimasa, Yasunao; Nakao, Kazuwa.

In: Journal of Clinical Investigation, Vol. 105, No. 9, 01.01.2000, p. 1243-1252.

Research output: Contribution to journalArticle

Aizawa-Abe, M, Ogawa, Y, Masuzaki, H, Ebihara, K, Satoh, N, Iwai, H, Matsuoka, N, Hayashi, T, Hosoda, K, Inoue, G, Yoshimasa, Y & Nakao, K 2000, 'Pathophysiological role of leptin in obesity-related hypertension', Journal of Clinical Investigation, vol. 105, no. 9, pp. 1243-1252. https://doi.org/10.1172/JCI8341
Aizawa-Abe M, Ogawa Y, Masuzaki H, Ebihara K, Satoh N, Iwai H et al. Pathophysiological role of leptin in obesity-related hypertension. Journal of Clinical Investigation. 2000 Jan 1;105(9):1243-1252. https://doi.org/10.1172/JCI8341
Aizawa-Abe, Megumi ; Ogawa, Yoshihiro ; Masuzaki, Hiroaki ; Ebihara, Ken ; Satoh, Noriko ; Iwai, Hidenori ; Matsuoka, Naoki ; Hayashi, Tatsuya ; Hosoda, Kiminori ; Inoue, Gen ; Yoshimasa, Yasunao ; Nakao, Kazuwa. / Pathophysiological role of leptin in obesity-related hypertension. In: Journal of Clinical Investigation. 2000 ; Vol. 105, No. 9. pp. 1243-1252.
@article{4102d03b7b794244a6adc137d7c0b875,
title = "Pathophysiological role of leptin in obesity-related hypertension",
abstract = "To explore the pathophysiological role of leptin in obesity-related hypertension, we examined cardiovascular phenotypes of transgenic skinny mice whose elevated plasma leptin concentrations are comparable to those seen in obese subjects. We also studied genetically obese KKA(y) mice with hyperleptinemia, in which hypothalamic melanocortin system is antagonized by ectopic expression of the agouti protein. Systolic blood pressure (BP) and urinary catecholamine excretion are elevated in transgenic skinny mice relative to nontransgenic littermates. The BP elevation in transgenic skinny mice is abolished by α1-adrenergic, β-adrenergic, or ganglionic blockers at doses that do not affect BP in nontransgenic littermates. Central administration of an α-melanocyte-stimulating hormone antagonist causes a marked increase in cumulative food intake but no significant changes in BP. The obese KKA(y) mice develop BP elevation with increased urinary catecholamine excretion relative to control KK mice. After a 2-week caloric restriction, BP elevation is reversed in nontransgenic littermates with the A(y) allele, in parallel with a reduction in plasma leptin concentrations, but is sustained in transgenic mice overexpressing leptin with the A(y) allele, which remain hyperleptinemic. This study demonstrates BP elevation in transgenic skinny mice and obese KKA(y) mice that are both hyperleptinemic, thereby suggesting the pathophysiological role of leptin in some forms of obesity-related hypertension.",
author = "Megumi Aizawa-Abe and Yoshihiro Ogawa and Hiroaki Masuzaki and Ken Ebihara and Noriko Satoh and Hidenori Iwai and Naoki Matsuoka and Tatsuya Hayashi and Kiminori Hosoda and Gen Inoue and Yasunao Yoshimasa and Kazuwa Nakao",
year = "2000",
month = "1",
day = "1",
doi = "10.1172/JCI8341",
language = "English",
volume = "105",
pages = "1243--1252",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "9",

}

TY - JOUR

T1 - Pathophysiological role of leptin in obesity-related hypertension

AU - Aizawa-Abe, Megumi

AU - Ogawa, Yoshihiro

AU - Masuzaki, Hiroaki

AU - Ebihara, Ken

AU - Satoh, Noriko

AU - Iwai, Hidenori

AU - Matsuoka, Naoki

AU - Hayashi, Tatsuya

AU - Hosoda, Kiminori

AU - Inoue, Gen

AU - Yoshimasa, Yasunao

AU - Nakao, Kazuwa

PY - 2000/1/1

Y1 - 2000/1/1

N2 - To explore the pathophysiological role of leptin in obesity-related hypertension, we examined cardiovascular phenotypes of transgenic skinny mice whose elevated plasma leptin concentrations are comparable to those seen in obese subjects. We also studied genetically obese KKA(y) mice with hyperleptinemia, in which hypothalamic melanocortin system is antagonized by ectopic expression of the agouti protein. Systolic blood pressure (BP) and urinary catecholamine excretion are elevated in transgenic skinny mice relative to nontransgenic littermates. The BP elevation in transgenic skinny mice is abolished by α1-adrenergic, β-adrenergic, or ganglionic blockers at doses that do not affect BP in nontransgenic littermates. Central administration of an α-melanocyte-stimulating hormone antagonist causes a marked increase in cumulative food intake but no significant changes in BP. The obese KKA(y) mice develop BP elevation with increased urinary catecholamine excretion relative to control KK mice. After a 2-week caloric restriction, BP elevation is reversed in nontransgenic littermates with the A(y) allele, in parallel with a reduction in plasma leptin concentrations, but is sustained in transgenic mice overexpressing leptin with the A(y) allele, which remain hyperleptinemic. This study demonstrates BP elevation in transgenic skinny mice and obese KKA(y) mice that are both hyperleptinemic, thereby suggesting the pathophysiological role of leptin in some forms of obesity-related hypertension.

AB - To explore the pathophysiological role of leptin in obesity-related hypertension, we examined cardiovascular phenotypes of transgenic skinny mice whose elevated plasma leptin concentrations are comparable to those seen in obese subjects. We also studied genetically obese KKA(y) mice with hyperleptinemia, in which hypothalamic melanocortin system is antagonized by ectopic expression of the agouti protein. Systolic blood pressure (BP) and urinary catecholamine excretion are elevated in transgenic skinny mice relative to nontransgenic littermates. The BP elevation in transgenic skinny mice is abolished by α1-adrenergic, β-adrenergic, or ganglionic blockers at doses that do not affect BP in nontransgenic littermates. Central administration of an α-melanocyte-stimulating hormone antagonist causes a marked increase in cumulative food intake but no significant changes in BP. The obese KKA(y) mice develop BP elevation with increased urinary catecholamine excretion relative to control KK mice. After a 2-week caloric restriction, BP elevation is reversed in nontransgenic littermates with the A(y) allele, in parallel with a reduction in plasma leptin concentrations, but is sustained in transgenic mice overexpressing leptin with the A(y) allele, which remain hyperleptinemic. This study demonstrates BP elevation in transgenic skinny mice and obese KKA(y) mice that are both hyperleptinemic, thereby suggesting the pathophysiological role of leptin in some forms of obesity-related hypertension.

UR - http://www.scopus.com/inward/record.url?scp=12944257370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12944257370&partnerID=8YFLogxK

U2 - 10.1172/JCI8341

DO - 10.1172/JCI8341

M3 - Article

C2 - 10791999

AN - SCOPUS:12944257370

VL - 105

SP - 1243

EP - 1252

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 9

ER -